• Multisite evaluation of the Asuragen NGS RNA Lung Cancer Kit demonstrates the assay’s superior performance
    7th February 2019NGS, Molecular Oncology, Non-Small Cell Lung Cancer

    Multisite evaluation of the Asuragen NGS RNA Lung Cancer Kit demonstrates the assay’s superior performance

    Results from a five-site study using the QuantideX NGS RNA Lung Cancer Kit* published in The Journal of Molecular Diagnostics demonstrate the assay’s high sensitivity, accuracy, and reproducibility in detecting actionable RNA [...]